Corporate | M&A Assignment

Hamilton has acted for HealthCap

Hamilton has act­ed for HealthCap VII L.P, a ven­ture cap­i­tal fund in­vest­ing in life sci­ence, in con­nec­tion with the in­vest­ment of ap­prox­i­mate­ly MSEK 60 in Modus Therapeutics Holding AB, a port­fo­lio com­pa­ny of Karolinska Development de­vel­op­ing the nov­el drug Sevuparin to treat peo­ple suf­fer­ing from Sickle Cell Disease. In con­nec­tion with HealthCap’s in­vest­ment, the ex­ist­ing share­hold­ers will con­vert out­stand­ing con­vert­ible loans in­to shares. The new eq­ui­ty in­vest­ment to­geth­er with the con­ver­sion amounts to ap­prox­i­mate­ly MSEK 140.

More news

More Assignments